BBNX
Beta Bionics, Inc.
NASDAQ · Healthcare · Medical - Equipment & Services · US
$17.58
−1.51%0
Insider buys (3m)
15
Insider sells (3m)
-$3.0M
Net value (3m)
+25.3%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Oct 28, 2026 | Hopman Mark · officer: Chief Commercial Officer | Sale | 821 | $20 |
| Oct 16, 2026 | Hopman Mark · officer: Chief Commercial Officer | Sale | 775 | $17 |
| Oct 5, 2026 | Hopman Mark · officer: Chief Commercial Officer | Sale | 370 | $19 |
| Sep 23, 2026 | Jones Christy · director | Sale | 6,430 | $23 |
| Sep 18, 2026 | Hopman Mark · officer: Chief Commercial Officer | Sale | 35,994 | $18 |
| Sep 17, 2026 | Hopman Mark · officer: Chief Commercial Officer | Sale | 30,779 | $20 |
| Sep 17, 2026 | Mensinger Mike · officer: Chief Product Officer | Sale | 2,650 | $22 |
| Sep 15, 2026 | Hopman Mark · officer: Chief Commercial Officer | Sale | 775 | $16 |
| Sep 10, 2026 | Hopman Mark · officer: Chief Commercial Officer | Sale | 36,870 | $18 |
| Sep 4, 2026 | Saint Sean · director, officer: President & CEO | Sale | 5,641 | $20 |
| Sep 3, 2026 | Saint Sean · director, officer: President & CEO | Sale | 16,867 | $19 |
| Sep 3, 2026 | Feider Stephen · officer: Chief Financial Officer | Sale | 6,675 | $19 |
| Sep 3, 2026 | Mensinger Mike · officer: Chief Product Officer | Sale | 4,375 | $19 |
| Sep 3, 2026 | Russell Steven Jon · officer: Chief Medical Officer | Sale | 4,221 | $19 |
| Sep 3, 2026 | Hopman Mark · officer: Chief Commercial Officer | Sale | 5,327 | $19 |
| Jul 2, 2026 | Feider Stephen · officer: Chief Financial Officer | Sale | 5,104 | $17 |
| Jul 2, 2026 | Feider Stephen · officer: Chief Financial Officer | Sale | 4,896 | $17 |
| Jul 2, 2026 | Feider Stephen · officer: Chief Financial Officer | M-Exempt | 4,896 | $5.10 |
| Jul 2, 2026 | Feider Stephen · officer: Chief Financial Officer | M-Exempt | 5,104 | $5.10 |
| Jun 30, 2026 | Feider Stephen · officer: Chief Financial Officer | Sale | 5,104 | $17 |
| Jun 30, 2026 | Feider Stephen · officer: Chief Financial Officer | Sale | 4,896 | $17 |
| Jun 30, 2026 | Feider Stephen · officer: Chief Financial Officer | M-Exempt | 4,896 | $5.10 |
| Jun 30, 2026 | Feider Stephen · officer: Chief Financial Officer | M-Exempt | 4,982 | $5.10 |
| Jun 25, 2026 | Hopman Mark · officer: Chief Commercial Officer | Sale | 1,258 | $15 |
| Jun 25, 2026 | Jones Christy · director | Sale | 1,406 | $15 |
| Jun 5, 2026 | Hopman Mark · officer: Chief Commercial Officer | Sale | 275 | $12 |
| Jun 5, 2026 | Jones Christy · director | Sale | 2,811 | $14 |
| Jun 3, 2026 | Feider Stephen · officer: Chief Financial Officer | Sale | 6,676 | $13 |
| Jun 3, 2026 | Hopman Mark · officer: Chief Commercial Officer | Sale | 5,329 | $13 |
| Jun 3, 2026 | Mensinger Mike · officer: Chief Product Officer | Sale | 4,378 | $13 |
Institutional positioning
13F filings over the trailing two quarters
New 58Increased 106Reduced 86Sold out 23
| Filer | Action | Shares | Filed |
|---|---|---|---|
| EVENTIDE ASSET MANAGEMENT, LLC | Increased | 6,253,673 | Aug 14, 2026 |
| EVENTIDE ASSET MANAGEMENT, LLC | Increased | 5,945,488 | May 15, 2026 |
| Soleus Capital Management, L.P. | Increased | 4,393,714 | Aug 11, 2026 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | Increased | 4,354,501 | May 14, 2026 |
| MORGAN STANLEY | Increased | 4,266,822 | Aug 13, 2026 |
| MORGAN STANLEY | Reduced | 4,227,634 | May 15, 2026 |
| Sands Capital Alternatives, LLC | Unchanged | 3,708,043 | Aug 13, 2026 |
| SANDS CAPITAL VENTURES, LLC | Increased | 3,708,043 | May 8, 2026 |
| FARALLON CAPITAL MANAGEMENT LLC | Reduced | 3,607,920 | May 15, 2026 |
| BlackRock, Inc. | Increased | 3,340,171 | Aug 7, 2026 |
| BLACKROCK, INC. | Increased | 3,038,595 | May 13, 2026 |
| POINT72 ASSET MANAGEMENT, L.P. | Increased | 2,525,040 | May 15, 2026 |
| Point72 Asset Management, L.P. | Reduced | 2,254,683 | Aug 14, 2026 |
| VESTAL POINT CAPITAL, LP | Increased | 2,211,518 | May 15, 2026 |
| RTW INVESTMENTS, LP | Reduced | 2,000,000 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Oct 28, 2026